Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021
The diagnostic value of interleukin-6 in distinguishing tuberculous pleurisy from malign effusion Source: Eur Respir J 2001; 18: Suppl. 33, 499s Year: 2001
An unusual presentation of anti-Jo-1 syndrome, mimicking lung metastases, with massive pleural and pericardial effusions Source: Eur Respir J 2004; 24: Suppl. 48, 506s Year: 2004
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Prognostic significance of neutrophil predominance in pleural fluid in patients with malignant effusion Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Occurrence of malignancy after an initial diagnosis of post-thoracoscopy fibrinous pleuritis Source: Annual Congress 2012 - Medical access to the pleura Year: 2012
Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
C-reactive protein in differentiation between tuberculous and malignant pleural effusions Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011
Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013
Algorithm for diagnostics of recurrent pleural effusions suspected to malignancy Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
Management of recurrent malignant pleural effusions Source: ERS Skills Course 2017 - Thoracoscopy and Pleural Techniques Year: 2017
Management of recurrent malignant pleural effusions Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques Year: 2019
Management of recurrent malignant pleural effusions Source: ERS Skills Course 2016 - Thoracoscopy and pleural techniques Year: 2016
Management of recurrent malignant pleural effusions Source: ERS Course 2019 - Thoracoscopy and Pleural Techniques, April 2019 Year: 2019
Management of recurrent malignant pleural effusions Source: ERS Skills Course 2016 Year: 2016
Management of recurrent malignant pleural effusions Source: ERS Skills Course 2018 - Thoracoscopy and pleural techniques Year: 2018
Pleural fluid interleukin-10 level in the diagnosis of tuberculous effusions Source: Eur Respir J 2002; 20: Suppl. 38, 581s Year: 2002
Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004
Diagnostic value of leptin in tuberculous pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 426s Year: 2004